Monitor for potential overhang as selling stockholders may sell shares into the market after the registration becomes effective. The TCG Crossover Funds hold a combined 5,338,078 shares (approx. 9.8% of outstanding) and could gradually reduce positions. Watch for volume spikes and price pressure post-effectiveness.
Price Chart
Executive Summary
Vor Biopharma filed an S-3 registration statement to register 5,338,078 shares of common stock for resale by TCG Crossover Funds, issued in a March 2026 private placement at $14.05/share ($75M gross). The company will not receive any proceeds. This is a routine registration rights fulfillment and does not represent new equity issuance or capital raise.
Key Facts
- Registers 5,338,078 shares for resale by selling stockholders (TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P.)
- Shares were issued in a private placement on March 30, 2026 at $14.05 per share, gross proceeds ~$75M to the company
- Company will not receive any proceeds from this resale offering
- Stock closed at $13.81 on April 24, 2026; market cap ~$675M
- Shares outstanding as of April 22, 2026: 54,185,737
Financial Impact
No financial impact to the company; selling stockholders may realize proceeds up to ~$73.7M at current market price
Risk Factors
- Potential selling pressure from the registered shares could weigh on stock price
- No new capital raised for the company; reliance on existing cash and future financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-182106 |
| Document: d27587dexfilingfees.htm | 0001193125-26-182106 |
| Document: d27587dex51.htm | 0001193125-26-182106 |
| Document: d27587dex232.htm | 0001193125-26-182106 |
| Document: 0001193125-26-182106-index-headers.html | 0001193125-26-182106 |
| Document: 0001193125-26-182106-index.html | 0001193125-26-182106 |
| Document: 0001193125-26-182106.txt | 0001193125-26-182106 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $23.37 $23.24 | ▼ −0.58% | ▲ +0.48% | $18.69 (−20.03%) |
Jul 9, 2026 12w ago | 3 | $19.14 $23.67 | ▲ +23.67% | ▲ +21.24% | $18.69 (−2.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $14.09 $19.75 | ▲ +40.17% | ▲ +38.28% | $18.69 (+32.65%) |
Jun 8, 2026 16w ago | Press Release | $13.29 $20.10 | ▲ +51.24% | ▲ +49.61% | $18.69 (+40.63%) |
May 7, 2026 21w ago | EFFECT | $16.08 $13.44 | ▼ −16.42% | ▼ −19.55% | $18.69 (+16.23%) |
Apr 27, 2026 22w ago | S-3 | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.69 (+29.97%) |
Apr 27, 2026 22w ago | DEFA14A | $14.38 $14.10 | ▼ −1.95% | ▼ −7.42% | $18.69 (+29.97%) |
Mar 27, 2026 27w ago | Press Release | $14.48 $14.12 | ▼ −2.49% | ▼ −15.23% | $18.69 (+29.07%) |
Mar 23, 2026 27w ago | Press Release | $12.15 $15.32 | ▲ +26.09% | ▲ +17.19% | $18.69 (+53.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access